Authors
Loading...
Review reveals poor survival and diagnostic limits for antibody-mediated rejection in lung transplant recipients, indicating a need for standardized treatment trials.
Bery et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: